Summary:
Miami Dade Medical Research Institute is conducting A 6 month safety and benefit study of inhaled investigational drug in the treatment of Pediatric patients 4-11 years with persistent asthma.
Qualified Participants Must:
• Be between 4 and 11 years of age
•
Have been diagnosed with Asthma at least 6 months before visit 1
Qualified Participants May Receive:
Stipend for their time and transportation
.